Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Bartels DB, Lip GY; GLORIA-AF Investigators..

J Am Coll Cardiol. 2017 Feb 21;69(7):777-785. doi: 10.1016/j.jacc.2016.11.061.

2.

[V Guideline of the Brazilian Society of Cardiology on Acute Myocardial Infarction Treatment with ST Segment Elevation].

Avezum Junior Á, Feldman A, Carvalho AC, Sousa AC, Mansur Ade P, Bozza AE, Falcão Bde A, Markman Filho BM, Polanczyk CA, Gun C, Serrano Junior CV, Oliveira CC, Moreira D, Précoma DB, Magnoni D, Albuquerque DC, Romano ER, Stefanini E, Santos ES, God EM, Ribeiro EE, Brito FS, Feitosa-Filho GS, Arruda GD, Oliveira GB, Lima GG, Dohman H, Liguori IM, Costa Junior Jde R, Saraiva JF, Maia LN, Moreira LF, Santos MA, Canesin MF, Coutinho MS, Moretti AM, Ghorayeb N, Vieira NW, Dutra OP, Coelho OR, Leães PE, Rossi PR, Andrade PB, Lemos Neto PA, Pavanello R, Costa RV, Bassan R, Esporcatte R, Miranda R, Giraldez RR, Ramos RF, Martins SK, Esteves VB, Mathias Junior W; Brazilian Society of Cardiology..

Arq Bras Cardiol. 2015 Aug;105(2 Suppl 1):1-105. doi: 10.5935/abc.20150107. Portuguese. No abstract available.

3.

[Guidelines of Sociedade Brasileira de Cardiologia for Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (II Edition, 2007) 2013-2014 Update].

Nicolau JC, Timerman A, Marin-Neto JA, Piegas LS, Barbosa CJ, Franci A, Avezum A Jr, Carvalho AC, Markman Filho B, Polanczyk CA, Rochitte CE, Serrano Júnior CV, Precoma DB, Silva Junior DG, Albuquerque DC, Stefanini E, Knobel E, Jatene FB, Feres F, Morcerf FA, Ganem F, Lima Filho FA, Feitosa Filho GS, Ferreira JF, Meneghetti JC, Saraiva JF, Silva LS, Maia LN, Baracioli LM, Lisboa LA, Dallan LA, Bodanese LC, Andrade MD, Oliveira Júnior M, Dutra OP, Coelho OR, Leães PE, Albuquerque PF, Lemos P, Kalil R, Costa RV, Esporcate R, Marino RL, Botellho RV, Meneghelo RS, Sprovieri SR, Timerman S, Mathias Júnior W; Sociedade Brasileira de Cardiologia..

Arq Bras Cardiol. 2014 Mar;102(3 Suppl 1):1-61. Portuguese. No abstract available.

4.

Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome.

Goldstein S, Bates ER, Bhatt DL, Cao C, Holmes D, Kupfer S, Martinez F, Spaeder J, Weitz JI, Ye Z, Zannad F; AXIOM investigators..

Thromb Haemost. 2014 Jun;111(6):1141-52. doi: 10.1160/TH13-07-0543.

PMID:
24671450
5.

[Brazilian guidelines on platelet antiaggregants and anticoagulants in cardiology].

Sociedade Brasileira de Cardiologia., Lorga Filho AM, Azmus AD, Soeiro AM, Quadros AS, Avezum A Jr, Marques AC, Franci A, Manica AL, Volschan A, De Paola AA, Greco AI, Ferreira AC, Sousa AC, Pesaro AE, Simão AF, Lopes AS, Timerman A, Ramos AI, Alves BR, Caramelli B, Mendes BA, Polanczyk CA, Montenegro CE, Barbosa CJ, Serrano CV Jr, Melo CC, Pinho C, Moreira DA, Calderaro D, Gualandro DM, Armaganijan D, Machado Neto EA, Bocchi EA, Paiva EF, Stefanini E, D'Amico E, Evaristo EF, Silva EE, Fernandes F, Brito FS Jr, Bacal F, Ganem F, Gomes FL, Mattos FR, Moraes Neto FR, Tarasoutchi F, Darrieux FC, Feitosa GS, Fenelon G, Morais GR, Correa Filho H, Castro I, Gonçalves I Jr, Atié J, Souza Neto JD, Ferreira JF, Nicolau JC, Faria Neto JR, Annichino-Bizzacchi JM, Zimerman LI, Piegas LS, Pires LJ, Baracioli LM, Silva LB, Mattos LA, Lisboa LA, Magalhães LP, Lopes MA, Montera MW, Figueiredo MJ, Malachias MV, Gaz MV, Andrade MD, Bacellar MS, Barbosa MR, Clausell NO, Dutra OP, Coelho OR, Yu PC, Lavítola PL, Lemos Neto PA, Andrade PB, Farsky PS, Franco RA, Kalil RA, Lopes RD, Esporcatte R, Heinisch RH, Kalil Filho R, Giraldez RR, Alves RC, Leite RE, Gagliardi RJ, Ramos RF, Montenegro ST, Accorsi TA, Jardim TS, Scudeler TL, Moisés VA, Portal VL.

Arq Bras Cardiol. 2013 Sep;101(3 Suppl 3):1-95. doi: 10.5935/abc.2013S009. Portuguese. No abstract available.

6.

[First guidelines on fat consumption and cardiovascular health].

Santos RD, Gagliardi AC, Xavier HT, Magnoni CD, Cassani R, Lottenberg AM; Sociedade Brasileira de Cardiologia., Arpadi Faludi A, Geloneze B, Scherr C, Kovacs C, Tomazzela C, Carla C, Barrera-Arellano D, Cintra D, Quintão E, Nakandakare ER, Fonseca FA, Pimentel I, Ernesto dos Santos J, Bertolami MC, Rogero M, Izar MC, Nakasato M, Teixeira Damasceno NR, Maranhão R, Cassani RS, Perim R, Ramos S; Sociedade Brasileira de Cardiologia..

Arq Bras Cardiol. 2013 Jan;100(1 Suppl 3):1-40. Portuguese. No abstract available.

7.

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS; dal-OUTCOMES Investigators..

N Engl J Med. 2012 Nov 29;367(22):2089-99. doi: 10.1056/NEJMoa1206797.

8.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators..

N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512.

9.

Vorapaxar in the secondary prevention of atherothrombotic events.

Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA; TRA 2P–TIMI 50 Steering Committee and Investigators..

N Engl J Med. 2012 Apr 12;366(15):1404-13. doi: 10.1056/NEJMoa1200933.

10.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators..

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277.

11.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators..

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819.

12.

[Wellens syndrome].

Appel-da-Silva MC, Zago G, Abelin AP, Pin WO, Dutra OP, Vaz R.

Arq Bras Cardiol. 2010 Apr;94(4):e116-9. Portuguese.

13.

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.

Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators..

Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017.

PMID:
19958854
14.

[II Brazilian guideline for severe heart disease].

Dutra OP, Besser HW, Tridapalli H, Leiria TL, Afiune Neto A, Simão AF, Sbissa AS, Casagrande E, Lima GG, Castro I, Gus I, Nesralla IA, Nonohay NC, Daubt N, Irigoyen MC, Kalil RA; Sociedade Brasileira de Cardiologia..

Arq Bras Cardiol. 2006 Aug;87(2):223-32. Portuguese. No abstract available.

15.

A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study.

Jang IK, Brown DF, Giugliano RP, Anderson HV, Losordo D, Nicolau JC, Dutra OP, Bazzino O, Viamonte VM, Norbady R, Liprandi AS, Massey TJ, Dinsmore R, Schwarz RP Jr.

J Am Coll Cardiol. 1999 Jun;33(7):1879-85.

16.

[Bedside cardiac catheterization. Advantages and disadvantages].

Vitola D, Nonohay NC, Guillermo-Cal L, Junges JF, Rotunno SM, Xavier SS, Vaz RC, Dutra OP, Azevedo A, Rodrigues R.

Arq Bras Cardiol. 1989 Jun;52(6):315-8. Portuguese.

PMID:
2604578
17.

[Changes in the ST segment in unstable angina pectoris. Its prognostic value].

Rodríguez R, Nonohay NC, Vitola D, García-Macedo R, Guillermo-Cal L, Wagner EM, Dutra OP, Cecin Vaz R, Azevedo A, Kornfeld J.

Arch Inst Cardiol Mex. 1986 Sep-Oct;56(5):399-402. Spanish.

PMID:
2948454
18.

[Predictive value of acute electrocardiographic changes and therapeutic response in unstable angina].

Rodrigues R, Nonohay N, Vitola D, Garcia-Macedo R, Guillermo-Cal L, Dutra OP, Vaz RC, Azevedo A, Kornfeld J.

Arq Bras Cardiol. 1986 Aug;47(2):83-6. Portuguese. No abstract available.

PMID:
3579650

Supplemental Content

Loading ...
Support Center